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Abstract: Eosinophilic colitis (EC) is a common cause of haematochezia in infants and young 
children. The exact pathomechanism is not understood, and the diagnosis is challenging. The role 
of microRNAs as key class of regulators of mRNA expression and translation in patients with EC 
has not been explored. Therefore, the aim of the present study was to explore the miRNA profile in 
EC with respect to eosinophilic inflammation. Patients enrolled in the study (n = 10) had persistent 
rectal bleeding, and did not respond to elimination dietary treatment. High-throughput microRNA 
sequencing was carried out on colonic biopsy specimens of children with EC (EC: n = 4) and controls 
(C: n = 4) as a preliminary screening of the miRNA profile. Based on the next-generation sequencing 
(NGS) results and literature data, a potentially relevant panel of miRNAs were selected for further 
measurements by real-time reverse transcription (RT)-PCR (EC: n = 14, C: n = 10). Validation by RT-
PCR resulted in significantly altered expression of miR-21, -31, -99b, -125a, -146a, -184, -221, -223, 
and -559 compared to controls (p ≤ 0.05). Elevation in miR-21, -99b, -146a, -221, and -223 showed 
statistically significant correlation to the extent of tissue eosinophilia. Based on our results, we 
conclude that the dysregulated miRNAs have a potential role in the regulation of apoptosis by 
targeting Protein kinase B/Mechanistic target of rapamycin (AKT/mTOR)-related pathways in 
inflammation by modulating Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-
κB)-related signalling and eosinophil cell recruitment and activation, mainly by regulating the 
expression of the chemoattractant eotaxin and the adhesion molecule CD44. Our results could serve 
as a basis for further extended research exploring the pathomechanism of EC. 
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1. Introduction 
Eosinophilic colitis (EC) is a frequent cause of lower gastrointestinal bleeding in the early years 
of life. The main clinical manifestations of EC are diarrhoea, and the presence of small amounts of 
mucus and fresh blood in the faeces of otherwise healthy infants [1]. The endoscopic features are 
generally intact macroscopic structures with swollen erythematous lymphoid follicles (LNH), patchy 
granularity, and aphthous lesions. Histologically, EC is characterized with eosinophil infiltrate [2,3]. 
The disease affects both breast-fed and soy or cow’s milk-based formula-receiving children. It has 
been suggested that the underlying cause could be a non-IgE-mediated hypersensitivity against 
unidentified dietary antigens in the maternal diet [4]. The most recent study addressing this condition 
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postulated that the recruitment of eosinophils in the colonic mucosa is affected by the expression of 
eotaxin-2, and degranulation of the perineural mast cells are frequent in EC; however, the exact 
pathomechanism of EC is unknown, and non-invasive diagnostic tests currently are not available [5–
9]. Recently there has been an exponential rise in EC recognition, with an estimated prevalence of 
3.3/100,000 [9]. 
Therapy of EC is based mostly on dietary alterations in the maternal diet or exclusive 
administration of amino acid-based formulas. Our study focused on patients unresponsive to dietary 
intervention therapy (both maternal diet restrictions and formula feeding). In these types of cases, 
persistent bleeding, weight loss, iron deficiency, and anaemia with thrombocytosis can occur; 
therefore, endoscopy can be considered. However, due to the overlapping symptoms of EC with 
Crohn’s disease (CD) and several other inflammatory conditions or physical damages of the colon, it 
is difficult to establish the final diagnosis [10–13]. This unique and clinically more relevant patient 
group were previously characterized in the context of endoscopic mucosal histology [10]. Our recent 
study is a continuation of efforts to investigate the characteristics of these patients. 
Regarding the genetic background of EC patients, there are only very limited data available—
mostly due to the lack of appropriate tissue specimens [14,15]. However, epigenetic factors gained 
more importance in recent years, also exerting remarkable effects in diseases with less significant 
genetic exposure. In some cases, these epigenetic regulators are more closely related to the 
phenotype; therefore, they have been proposed as suitable biomarkers [16–18]. 
One of the most evolving research areas in epigenetics is that of microRNAs (miRs), the small 
(20–22 bp) noncoding sequences capable of repressing mRNA translation and affecting biological 
processes at mRNA and protein level [19]. An increasing number of studies report specific expression 
alterations of miRs in different gastrointestinal diseases, including eosinophil-associated disorders 
such as airway allergies or eosinophilic esophagitis (EOE) [16,17,20,21]. However, to the best of our 
knowledge, data regarding the involvement of miRs in the pathomechanism of EC has not yet been 
published [20–22]. 
Therefore, the major aim of our present study was to identify disease-specific miR expression in 
a group of patients with persistent haematochezia after maternal exclusion diet (Figure 1). Differences 
may contribute to the diagnostic confirmation of EC in cases with poor progression. Moreover, we 
aimed to investigate the pool of potential target genes of the altered miRs to gain insight into the 
pathomechanism of EC. 
 
Figure 1. Patient selection chart. EC: eosinophilic colitis. 
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2. Results 
2.1. EC-Specific miR Expression Profile by Next-Generation Sequencing (NGS) 
In the EC biopsies, 456 miRs were dysregulated in some extent, of which 79 miRs had a fold 
change ≥1.5 in EC patients compared to controls (p ≤ 0.05). Seventy-one of these miRs were 
upregulated, and eight miRs showed lower expression compared to the controls (Table S1). Based on 
the results of NGS, but with molecular biological relevance as a higher priority, nine dysregulated 
miRs previously connected to tissue eosinophilia, eosinophil cell-related signalling apoptosis, and 
inflammation by previous studies were selected for method validation and further analysis by real-
time reverse transcription (RT)-PCR [20,21,23–32]. 
2.2. Expression of miRs Selected for Further Analysis by RT-PCR 
Similar to the changes found by NGS, the expression of the nine miRs selected for method 
validation and further analysis by RT-PCR showed statistically significant differences in the colonic 
mucosa of paediatric patients with EC compared to controls (p ≤ 0.05). The expression of miR-21, -31, 
-99b, -125a, -146a, -184, -221, and -223 was significantly elevated, and that of miR-559 significantly 
decreased in the colonic mucosa of children with EC compared to controls (Figure 2). 
 
Figure 2. Expression of selected miRs in the colonic mucosa of children with eosinophilic colitis (EC) 
and controls (C). MiRs were selected based on the results of next-generation sequencing (NGS), and 
their colonic expression was validated by real-time reverse transcription polymerase chain reaction 
(RT-PCR). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. C. 
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2.3. Correlation of miR Expression with Tissue Eosinophil Counts 
From the PCR-validated miR panel, expression of miR-21 (r = 0.51; 95% CI = 0.15–0.77; p = 0.009), 
-99b (r = 0.60; 95% CI = 0.25–0.81, p = 0.002), -146a (r = 0.62, 95% CI = 0.29–0.82, p = 0.001), -221 (r = 0.78, 
95% CI = 0.78, p = 0.53–0.90, p < 0.0001) and -223 (r = 0.59. 95% CI = 0.22–0.81, p = 0.0041) showed a 
significantly positive correlation with the number of eosinophil granulocytes in paediatric patients 
with EC. MiR-125a, -31, -184, and 559 showed similar tendency, but the correlations with eosinophil 
numbers were statistically not significant (Figure 3). 
 
Figure 3. Correlation of miR-21, -99b, -146a, -221, and -223 with the extent of tissue eosinophilia in the 
colonic mucosa of paediatric patients with eosinophilic colitis. Class I: 0–10 eosinophil/high power 
field (eo/HPF), Class. II: 10–20 eo/HPF, Class III: 20–40 eo/HPF, Class IV: >40 eo/HPF, area of HPF = 
0.2 mm2. Solid lines represent a regression line with dotted lines depicting 95% CI. 
2.4. Results of Bioinformatics Analysis 
MiRTarBase database contained 386 reporter assay validated targets of the NGS miR profile 
found in EC. From this list expression of 100 entities were reported in epithelial tissue. Annotation of 
these 100 entities with gene ontology (GO) terms (biological process domain), and enrichment 
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analysis resulted in 24 GO term categories. The most abundant terms were connected with immune 
response, regulation of apoptosis, transcription regulation, and cell proliferation (Table S2). 
3. Discussion 
EC in infancy is in most cases a benign self-limiting disease associated with abdominal pain, 
intestinal dismotility, and mucosal eosinophilia occurring predominantly in the first six months of 
life [2]. However, several cases with overall poor progression and persistent rectal bleeding were 
reported (including in our study population). It is of high importance to investigate the 
pathomechanism and explore the diagnostic potential regarding these particularly sensitive patients. 
The exact pathomechanism of EC is not understood, and its causative therapy is not available in many 
cases [10,11,33]. 
Recently, the role of epigenetic factors came into focus as key determinants in the pathogenesis 
of different gastrointestinal diseases, including IBD and EOE, frequent forms of eosinophil-associated 
gastrointestinal disorders (EGID), and bronchial asthma. The expression of several miRs showed a 
strong correlation with the extent of eosinophil infiltration in the biopsy samples of patients with 
EOE, and were also dysregulated in their serum [21]. In the current study, we screened the miRNA 
profile on low patient count in EC with NGS, and based on these preliminary results, we selected a 
panel of miRNAs strongly connected with eosinophilic inflammation for further analysis. We 
analysed the selected miRNA with RT-PCR methods on a higher patient number. The panel consisted 
of nine miRs: miR-21, -31, -99b, -125a, -146a, -184, -221, -223, and -559. Dysregulation of six of these 
miRs—miR-21, -99b, -125a, -146a, -221, and -223—were previously reported in EOE [20,21]. We 
selected three additional miRs with strong connection to eosinophil cell recruitment and activation, 
as described earlier in other conditions. [28,29,32]. The selected miRs also have several potential 
effects in the modulation of inflammatory pathways not directly affecting eosinophil cells. In the 
following paragraphs, we will discuss the potential target points, starting with the general pathways 
of apoptosis followed by the closely relevant molecular events of eosinophilic inflammation. 
From the selected miR panel, miR-21, -99b, and -221 are closely related to apoptosis by the 
potential regulation of the PI3K/Akt/mTOR pathway [34–36]. Negative regulation of apoptosis in 
lymphoid cells and eosinophils could contribute to their accumulation and prolonged survival in the 
colonic tissue [37]. This mechanism could also be an important factor in tissue infiltration and the 
subsequent formation of LNH—a frequent endoscopic finding in EC. MiR-559 is an inhibitor of 
ERBB2 expression. Eosinophil peroxidase—a secreted effector molecule of activated eosinophil 
cells—is a ligand of ERBB2, and the downstream signalisation originating from ERBB2 has significant 
proliferative effects; hence, it could contribute to the dwelling caused by prolonged accumulation 
and activation of eosinophils on inflammatory sites [28]. 
On the other hand, positive regulation of apoptosis—on which the dysregulated miRs could also 
have a potential effect according to our present analysis—could slow down the turnover and 
proliferation of epithelial cells in the colonic tissue, leading to the impairment of intestinal barrier 
function and the facilitation of inflammatory processes [38–40]. This phenomenon as a histologic 
finding has been reported in connection with EC. Apoptotic cell-specific histochemical TUNEL assay 
on biopsies labelled with epithelial cell-specific antibodies identified an increased number of 
apoptotic epithelial cells in the lamina propria of rectosigmoid biopsy specimens originating from 
infants with haematochezia previously diagnosed with allergic/eosinophilic colitis [40]. 
Similar to the observations in EOE, in the present study we demonstrated significantly elevated 
expression of miR-21, -146a, and -223 in the colonic mucosa of paediatric patients with EC compared 
to controls, and it was strongly correlated with the extent of tissue eosinophilia. Furthermore, we 
found a positive correlation between the expression changes of miR-99b and -221 and the number of 
tissue eosinophils in the colonic mucosa of EC patients [41,42] (Figure 3). The correlations suggest 
that these miRs could be actively connected to the pathomechanism of EC. A composite graph of the 
possible interacting points of these miRs with respect to inflammation and tissue eosinophilia is 
presented in Figure 4. 
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Figure 4. Composite summary graph of the potential target points of the miRs correlated with tissue 
eosinophil level. Abbreviations: inhibitor of kappa B kinase (IKK), interleukin 1, 6, 8, 13 (IL-1, -6, -8,  
-13), interleukin receptor-1R, -33R, 18R (IL-1R, -33R, -18R), interleukin-1 receptor-associated kinase 1 
(IRAK1), mammalian target of rapamycin complex (mTORc), microRNA-21, -31, -99b, -146a, -184,  
-221, -223 (miR-21, -31, -99b, -146a, -184, -221, -223), myeloid differentiation primary response 88 
(MyD88), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), nuclear factor of 
activated T-cells, cytoplasmic 1 (NFATc1), nuclear factor of kappa light polypeptide gene enhancer in 
B cells inhibitor (IκB), phosphatase and tensin homolog (PTEN), phosphatidylinositol (3,4,5)-
trisphosphate (PIP3), phosphatidylinositol 4,5-bisphosphate (PIP2), phosphatidylinositol-3-kinase 
(PI3K), phosphoinositide dependent protein kinase (PDK), programmed cell death protein 4 
(PDCD4), protein kinase B (Akt), receptor activator of nuclear factor kappa-B ligand (RANKL), TNF 
receptor associated factor-6 (TRAF6), Toll-like receptor-1-2, 4-6 (TLR 1-2, 4-6), tumor necrosis factor 
alpha (TNFα), tumor necrosis factor, α-induced protein 3 (A20). 
Certain dysregulated miRs in the colonic mucosa of children with EC (e.g., miR-125a, -146a, and 
-223 as identified in our present experiments) are also related to eosinophil cell line differentiation, 
activation, and recruitment [37]. Lu et al. found a connection between miR-223 deficiency and 
increased eosinophil progenitor cell proliferation in an ex vivo bone marrow-derived eosinophil 
culture system [43]. It is inferred from bone marrow culture experiments that miR-125a and -146a are 
also parts of the regulation network of eosinophil cell maturation [41]. To further investigate the 
relationship between miRs and eosinophil function in EC, additional studies would be needed on 
eosinophil granulocytes freshly isolated from the colonic tissues of EC patients. 
MiR-21 has been reported to be the most frequently upregulated miR in eosinophil-related diseases 
[21,23]. It is a complex regulator of eosinophil cell fate, activation and survival. MiR-21 overexpression 
is able to increase eosinophil progenitor cell growth, it has a pro-survival effect on eosinophils via 
granulocyte-macrophage colony-stimulating factor (GM-CSF), and acts towards Th2 polarization of the 
adaptive immune processes [23,25–27]. 
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The correlation of miR-221 expression with airway tissue eosinophilia has been reported in a 
murine model of bronchial asthma. In this model, the level of miR-221 was also correlated with IL-4 
secretion, presumably via phosphatase and tensin homolog (PTEN) and nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) protein related pathways that are potent inductors of 
tissue eosinophil infiltration [42]. Increased prevalence of EC has been reported amongst patients 
with PTEN hamartoma tumour syndromes [44]. MiR-21 and -221 are two miRs which showed 
significant elevation according to our measurements, and have been connected to the regulation of 
PTEN gene expression [36,45]. PTEN protein is a mon-redundant master regulator of the PI3K 
signalling pathway. Humans are highly sensitive of PTEN dosage, and alterations in the 
PI3K/Akt/mTOR pathway has been connected to eosinophil cell-related conditions [46–48]. MiR-99b 
is a member of the miR-99 family, and is also a potent regulator of the PI3K/Akt/mTOR pathway. 
Besides the effects on eosinophil cell survival, this pathway is active in the tissues of inflammation 
sites, acting as a mediator of wound healing [35]. 
MiR-184 targets the NFAT1 transcript directly. Deficiency in the NFAT1 protein product could 
lead to elevated IL-5, IL-2, and IL-13 production. These cytokines promote eosinophil cell survival 
and recruit via upregulation of eotaxin levels [28]. 
MiR-31 levels are positively correlated with the expression of CD44 adhesion molecule, a 
promoter of tissue eosinophilia. Expression of CD44 in epithelial cells could promote eosinophil 
migration and activation [31]. It has been demonstrated that changes in CD44 adhesion molecule 
levels in epithelial cells is a major component of tissue alterations in EOE, and promotes eosinophil 
and leukocyte migration and activation on the site of inflammation [32]. 
A limitation of our present study is that biopsies from age-matched healthy subjects could not 
be obtained. However, we enrolled the youngest possible patients to the control group in order to 
minimize these effects on the results. To completely eliminate the possible effect of age-related 
differences, only samples originating from autopsy procedures of infants involved in accidents or 
who suffered sudden infant death would be completely applicable. 
In summary, to the best of our knowledge, we conducted the first experiments in order to define 
the miR profile specific to EC. Using bioinformatics tools, we assessed the pool of target genes 
potentially affected by the miRs dysregulated in the colon of children with EC having persistent rectal 
bleeding, unresponsive to dietary therapies. Our results defined several possible target point for miRs 
on the molecular biological events of eosinophilic inflammation, and therefore could serve as a base 
for further investigations of the pathomechanism of EC. 
4. Materials and Methods 
4.1. Patients 
Samples from all patients enrolled in the study were obtained at the 1st Department of 
Pediatrics, Semmelweis University, Budapest, Hungary. Colon pinch biopsies were taken from 10 
children with EC and 14 controls. Clinical characteristics and laboratory parameters of the patients 
are shown in Table 1. Patients enrolled in the study had persistent rectal bleeding, and they were 
unresponsive to dietary intervention therapies. Patients underwent colonoscopy in order to exclude 
IBD and other organic causes of long-lasting haematochezia. The overall symptoms, long term 
follow-up, and endoscopic features of the patients did not justify the consideration of monogenic 
origin. Subsequent diagnosis of CD (without monogenic cause) was obtained in one patient, who was 
therefore excluded from the study. Diagnosis of EC was based on clinical history, physical 
examination (no perianal fissure), laboratory findings (infections excluded), endoscopic findings 
(focal erythema, LNH, and aphta), and pathological evaluation of tissue specimens (average 
eosinophil count/five high power field (eo/HPF) > 20, HPF area = 0.2 mm2) with long-term follow-up 
of the patients. Microscopic evaluation was open-label conducted by a skilled pathologist as a part of 
diagnostic processes. Control children underwent colonoscopy to assess the cause of failure to thrive 
or suspicion of polyp or Meckel-diverticulum. All specimens in the control group showed normal 
macroscopic and histologic features. Biopsies were immediately snap-frozen and stored at −80 °C 
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until further experiments. Written informed consent was obtained from the parents prior to the 
procedure, and the study was approved by the Semmelweis University Regional and Institutional 
Committee for Research Ethics (TUKEB No.: 10408/2012, Date: 30 March 2012). 
Table 1. Clinical characteristics and laboratory parameters of patients enrolled in the study (A) in the 
next-generation sequencing groups; and (B) in the real-time reverse transcription polymerase chain 
reaction validation groups. BMI: body mass index, CRP: C-reactive protein; Data are presented as 
mean ± SD * p ≤ 0.05 vs. Control, *** p ≤ 0.0001 vs. Control. 
A Control Eosinophilic Colitis 
n 4 4 
Male/Female 2/2 3/1 
Age (months) 136.5 ± 35.78 8.88 ± 5.14 * 
BMI (kg/m2) - 18.66 ± 3.79 
Iron (µmol/L) 10.75 ± 2.5 13.25 ± 3.57 
Albumin (g/L) 51.75 ± 8.81 - 
Haemoglobin (g/L) 134.3 ± 7.76 121.8 ± 3.64 
Haematocrit (%) 0.39 ± 0.02 0.34 ± 0.013 
Platelet count (Giga/L) 325.8 ± 21.10 440.5 ± 57.81 
CRP (mg/L) 1.25 ± 1.4  0 
B Control Eosinophilic Colitis 
n 14 10 
Male/Female 6/8 8/2 
Age (months) 29.82 ± 17.08 5.7 ± 4.76 *** 
BMI (kg/m2) 16.15 ± 1.6 16.21 ± 1.74 
Length-weight percentile (%) - 
42.25 ± 34.92  
1/10 overweight  
1/10 underweight 
Iron (µmol/L) 15.70 ± 4.9 9.89 ± 5.62 * 
Albumin (g/L) 45.8 ± 2.01 44 ± 4.24 
Haemoglobin (g/L) 122.1 ± 12.26 112.6 ± 8.32 * 
Haematocrit (%) 35.18 ± 2.8 32 ± 1.94 
Platelet count (Giga/L) 364.6 ± 87.09 394.5 ± 104.1 
CRP (mg/L) 0.79 ± 1.4 3.44 ± 8.49 
4.2. RNA Isolation 
Total RNA isolation from the colonic biopsies was conducted with TRIzol reagent (Ambion, 
Austin, TX, USA) for the next-generation sequencing (NGS) and Quick-RNA MiniPrep isolation kit 
(Zymo Research, Irvine, CA, USA) for the real-time reverse transcription polymerase chain reaction 
(RT-PCR) measurements, according to the manufacturer’s protocol. 
4.3. cDNA Library Preparation and NGS 
A cDNA library for small RNA-Seq was generated from 1 µg total RNA samples derived from 
the colonic mucosa of paediatric EC patients (EC: n = 4) and controls (C: n = 4) using TruSeq Small 
RNA Sample Preparation Kit (Illumina, San Diego, CA, USA) according to the manufacturer’s 
protocol. Fragment size distribution and molarity of libraries were checked on Agilent BioAnalyzer 
DNA1000 chip (Agilent Technologies, Santa Clara, CA, USA). Concentration of small RNA libraries 
were set to 10 nM, and cluster generation was done using TruSeq SR Cluster kit v3-cBot-HS kit on 
cBot instrument, then a single read 50 bp sequencing run was performed on Illumina HiScan SQ 
instrument (Illumina, San Diego, CA, USA) carried out by UD-GenoMed Medical Genomic 
Technologies Ltd. (Debrecen, Hungary). 
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4.4. RT-PCR 
RT-PCRs were performed on colonic biopsy samples of EC patients (n = 14) and controls (n = 10). 
Total RNA was reverse-transcribed using TaqMan MicroRNA Reverse Transcription Kit (Life 
Technologies, Carlsbad, CA, USA). MiRs were selected for validation according to the NGS results, 
and their expression was determined by RT-PCR using TaqMan Universal PCR Master Mix No 
AmpErase UNG (Life Technologies). Measurements were carried out on a LightCycler 480 
instrument (Roche, Basel, Switzerland). Relative expression level was calculated by the ΔΔCq 
formula, using U6 as an internal standard. TaqMan miR assays (miR-21: ID: 000397, miR-31: ID: 
002279, miR-99b: ID: 000436, miR-125a: ID: 002198, miR-146a: ID: 000468, miR-184: ID: 000485, miR-
221: ID: 000524, miR-223: ID: 002295, miR-559: ID: 001527, U6: ID: 001973) were used according to the 
manufacturer’s instructions. 
4.5. Bioinformatics Analysis of the Whole NGS miR Profile 
Experimentally validated (reporter assay) target genes were selected from the MiRTarBase 
database (Available online: http://mirtarbase.mbc.nctu.edu.tw) [49]. Target genes were filtered for 
site of expression reported according to the tissue expression database of UniProt (Available online: 
http://www.uniprot.org) [50]. The Database for Annotation, Visualization and Integrated Discovery 
(DAVID) bioinformatics tool was used to annotate the resulting list in the Biological process domain 
of the Gene Ontology (GO) database [51–54]. Enrichment analysis was carried out on the results with 
an established 0.01 threshold of the modified Fisher Exact p-value (EASE) scores of the enriched 
categories adjusted with the Benjamini–Hochberg correction method, and 10 entities threshold for 
group count. 
4.6. Determination of Eosinophil Counts in the Colonic Tissue of EC Patients 
Colonic tissue eosinophil counts were assessed in the microscopic slides by a pathologist with 
an assumption of representativeness. Evaluation of the specimens was open-label and conducted as 
a part of the normal diagnostic procedure. Paraffin-embedded tissue samples and fresh-frozen 
specimens were taken within close vicinity of each other. Eosinophil cells were detected by standard 
Hematoxylin and Eosin (H&E) staining (ST5020 Multistainer, Leica Microsystems GmbH, Wetzlar, 
Germany). Eosinophils in the lamina propria were counted in five random high-power fields (HPF: 
area of tissue covered by a ×40 light microscope objective: 0.2 mm2) selected from an eosinophil-dense 
part of the slides, on optical microscopy (BX51TF, Olympus, Tokyo, Japan). More than 20 eo/HPF was 
the cut-off number for EC (reference of histological evaluation presented in Figure 5). Based on the 
average number of eosinophil granulocytes in five HPFs (HPF area = 0.2 mm2), patients were divided 
into four categories (Class I: 0–10 eo/HPF, Class II: 10–20 eo/HPF, Class III: 20–40 eo/HPF, Class IV: 
>40 eo/HPF). 
Correlation between tissue eosinophil counts and miR expressions was calculated using a 
Spearman method assuming Gaussian distribution of the data. 
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Figure 5. Reference of the histologic assessment. Detection of eosinophil cells with Hematoxylin and 
Eosin (H&E) staining: 3–4/HPF eosinophil cells were detectable in normal biopsy (A, B). In a patient 
with eosinophil colitis, 100–120 eosinophils per HPF are seen (C, D). 
4.7. Statistical Analysis 
Statistical analysis was performed using the GraphPad statistical software package (GraphPad 
Software, La Jolla, CA, USA). Shapiro–Wilk test was used to test normality. Data were analysed by 
unpaired, two-tailed t-test and presented as mean ± standard error of the mean (SEM) and normalized 
to the control group. Two-tailed p-values were estimated in all the statistical calculations, and results 
were filtered after a 0.05 p-value threshold for significance. 
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/5/1050/s1. 
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